Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H27ClF2O5 |
Molecular Weight | 444.897 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]3(F)[C@@]2([H])C[C@H](F)C4=CC(=O)C(Cl)=C[C@]34C
InChI
InChIKey=GGXMRPUKBWXVHE-MIHLVHIWSA-N
InChI=1S/C22H27ClF2O5/c1-10-4-11-12-5-15(24)13-6-16(27)14(23)7-19(13,2)21(12,25)17(28)8-20(11,3)22(10,30)18(29)9-26/h6-7,10-12,15,17,26,28,30H,4-5,8-9H2,1-3H3/t10-,11+,12+,15+,17+,19+,20+,21+,22+/m1/s1
Molecular Formula | C22H27ClF2O5 |
Molecular Weight | 444.897 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Halometasone, a high-potency topical glucocorticoid that inhibits inflammation, epidermal hyperplasia, and allergic reactions, constrict blood vessels and relieve pruritus. Halometasone as the cream is used for the treatment of patients with chronic psoriasis vulgaris, eczematous dermatoses, and occupational contact dermatitis. Besides, this drug can reduce acute adverse effects induced by pulsed dye laser for the treatment of port wine stain (PWS) birthmarks. Halometasone acts via the binding to steroid receptors to modulate the protein synthesis and to regulate the function of inflammatory cells and lysosomes and ultimately to reduce inflammatory responses.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P04150 Gene ID: 2908.0 Gene Symbol: NR3C1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/29250537 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/29250537
1.41% of halometasone cream used for consecutive 7 days on a lesion area of 400 cm2 can be absorbed via the skin
Route of Administration:
Topical
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:01:33 GMT 2023
by
admin
on
Fri Dec 15 15:01:33 GMT 2023
|
Record UNII |
J69Z9UU41Z
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
D07AC12
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
||
|
WHO-VATC |
QD07AC12
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
26416
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
PRIMARY | RxNorm | ||
|
4647
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
PRIMARY | |||
|
DB13728
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
PRIMARY | |||
|
9846332
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
PRIMARY | |||
|
1352
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
PRIMARY | |||
|
C036518
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
PRIMARY | |||
|
CHEMBL1587228
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
PRIMARY | |||
|
C170038
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
PRIMARY | |||
|
DTXSID1048382
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
PRIMARY | |||
|
50629-82-8
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
PRIMARY | |||
|
256-664-9
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
PRIMARY | |||
|
100000083923
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
PRIMARY | |||
|
SUB08001MIG
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
PRIMARY | |||
|
m5903
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
PRIMARY | Merck Index | ||
|
J69Z9UU41Z
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
PRIMARY | |||
|
HALOMETASONE
Created by
admin on Fri Dec 15 15:01:34 GMT 2023 , Edited by admin on Fri Dec 15 15:01:34 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SOLVATE->ANHYDROUS |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |